New therapy for "black fever" is 95% effective: India licenses the first oral drug for visceral leishmaniasis, a lethal disease of poverty.
D000284:Administration, Oral; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D007194:India; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000401:mortality; D010767:Phosphorylcholine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011203:Poverty
D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine